Tobacco / Nicotine Cessation Treatment
Covered by Aetna in California

Varenicline (generic Chantix) 0.5mg daily × 3 days, then 0.5mg twice daily × 4 days, then 1mg twice daily × 12 weeks (first-line pharmacotherapy per USPSTF Grade A recommendation; most effective single agent — approximately doubles quit rates vs. placebo, NNT ~5 for 6-month abstinence); set a quit date between days 8–35 of treatment. Bupropion SR 150mg twice daily × 12 weeks (second-line or combination option — also treats concurrent depression; start 1 week before quit date; avoid with seizure history or eating disorders)

Nicotine replacement therapy combinations — patch 21mg/14mg/7mg (8-week taper) + nicotine gum 2–4mg PRN for breakthrough cravings (combination NRT equivalent in efficacy to varenicline per Cochrane review); nicotine nasal spray (Nicotrol NS) for rapid-onset craving relief; Nicotrol inhaler for behavioral oral substitution. Cytisine (off-label in US — plant-derived partial nicotinic agonist similar to varenicline mechanism; available OTC in some countries; limited US formulary access). Combination varenicline + NRT patch has evidence for superior abstinence rates vs. monotherapy in highly dependent smokers (>20 cigarettes/day).

Yes — all FDA-approved prescription cessation medications are covered at $0 cost-share for Aetna CA non-grandfathered commercial plan members under the ACA preventive mandate (USPSTF Grade A). Generic varenicline and bupropion SR covered. Nicotrol NS, Nicotrol Inhaler, and NRT patches covered when prescribed. OTC nicotine products (gum, patch, lozenge) covered only with prescription. Limits: typically 2 cessation attempts per 12-month period covered under the preventive benefit.

USPSTF 2021 recommends clinician-delivered cessation interventions for all tobacco users (Grade A — highest recommendation level). Varenicline is more effective than bupropion and combination NRT alone; combining varenicline with NRT patch shows additive benefit for heavy smokers. Bupropion is preferred when concurrent depression, seasonal affective disorder, or significant weight-gain concern is present. For pregnant patients: NRT (patch) is the only pharmacotherapy with acceptable safety data; varenicline and bupropion are not recommended in pregnancy. Psychiatric adverse effects of varenicline (neuropsychiatric events) are substantially lower than initial FDA warnings suggested; the black box warning was removed in 2016. Behavioral counseling significantly enhances pharmacotherapy success — refer patients to the California Smokers' Helpline (1-800-NO-BUTTS, free telephone counseling, evidenced-based, available in 6 languages).

Under the ACA preventive services mandate (Section 2713, USPSTF Grade A), Aetna California non-grandfathered commercial plans must cover FDA-approved tobacco cessation medications at zero cost-share — no copay, no deductible — for at least two cessation attempts per year. This includes prescription varenicline, bupropion SR, and all forms of NRT when prescribed. 'Grandfathered' plans (generally plans unchanged since March 23, 2010 with no significant benefit changes) are exempt, but these are increasingly rare. If you receive a bill for cessation medications, this may be a billing error — Aetna CA members can appeal citing PHSA § 2713(a)(1) and USPSTF's Grade A recommendation for tobacco cessation counseling and intervention.

Yes. Vivid dreams and insomnia are among the most commonly reported side effects of varenicline, occurring in approximately 10–15% of users. Management options include: taking the evening dose immediately after dinner (rather than before bed) to reduce sleep disruption; reducing to 0.5mg twice daily instead of 1mg — lower dose still doubles quit rates vs. placebo and is better tolerated; switching to bupropion SR 150mg twice daily, which has a different mechanism (norepinephrine-dopamine reuptake inhibition) and avoids the dream side effect; or using high-dose combination NRT (21mg patch + 4mg gum PRN). The black box psychiatric warning for varenicline was removed in 2016 after the EAGLES trial showed no increased psychiatric risk over placebo — vivid dreams are not a safety concern, just a tolerability issue.

Absolutely — combining pharmacotherapy with behavioral counseling significantly improves long-term quit success (6-month abstinence rates increase from ~20% with medication alone to ~30–35% with combination). The California Smokers' Helpline (1-800-NO-BUTTS) offers free telephone counseling from trained specialists, mobile app support at nobutts.org, and proactive call-back programs — all at no cost to any California resident regardless of insurance. Dr. Bhavsar will provide a formal referral to the Helpline as part of your visit documentation. For Spanish speakers: 1-800-45-NO-FUME. For smokers seeking to quit chewing tobacco or dip: 1-800-844-CHEW.

Yes. The ACA preventive benefit and Aetna CA policy apply to tobacco/nicotine use disorder broadly — including e-cigarette and nicotine vaping cessation. The pharmacotherapy approach is the same: varenicline reduces nicotine craving regardless of delivery form, and NRT patch addresses nicotine withdrawal. However, e-cigarette nicotine delivery is highly efficient and pod-based systems often deliver nicotine at concentrations equivalent to 1–2 packs of cigarettes per pod — many vapers have very high nicotine dependence. Dr. Bhavsar will assess your daily usage pattern and Fagerström-adapted score for vaping to determine appropriate medication strength and whether combination therapy is warranted.

Yes. Aetna commercial plans cover telehealth visits for Tobacco / Nicotine Cessation in California. TeleDirectMD (Dr. Parth Bhavsar, MD, NPI: 1104323203) is an in-network telehealth provider with Aetna in California. Your standard Aetna telehealth copay applies — typically $10–$40 for most commercial plans. If clinically appropriate, your prescription is sent to your California pharmacy immediately after your visit.

Most Aetna commercial plans in California have telehealth copays of $10–$40. Often $0–$20 for employer plans. Your exact cost depends on your specific plan and whether your deductible has been met. Log into your Aetna member portal or call the member services number on your card to verify your telehealth copay before your smoking cessation treatment visit. Self-pay is always available for a flat $49 if you prefer to skip insurance.

If your specific Aetna plan is not in-network with TeleDirectMD in California, or if your deductible has not yet been met, you can book as a self-pay patient for a flat $49 fee — same physician, same quality of care, no insurance needed. You may also be eligible to submit an out-of-network claim to Aetna for partial reimbursement depending on your plan's out-of-network benefit.

TeleDirectMD typically offers same-day and next-day video visits. Book at teledirectmd.com/book-online and select a time that works for you. Most patients are seen within a few hours of booking during business hours. Your smoking cessation treatment symptoms are evaluated by Dr. Bhavsar, MD — not a nurse practitioner or PA — ensuring you receive a board-certified clinical assessment.

Yes. TeleDirectMD is operated by Dr. Parth Bhavsar, MD (NPI: 1104323203), a board-certified Family Medicine physician. TeleDirectMD is LegitScript certified, HIPAA compliant, and is contracted as an in-network telehealth provider with Aetna in California. Claims are billed using standard CPT codes (99213/99214) and submitted electronically to Aetna.

Yes. Telehealth visits with a licensed physician are qualified medical expenses eligible for FSA (Flexible Spending Account) and HSA (Health Savings Account) payment. If your Aetna plan applies your deductible first, your FSA or HSA card can be used to pay your portion. The $49 self-pay option is also FSA/HSA eligible.